British Columbia Investment Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-400,000
Closed -$8.84M 807
2023
Q2
$8.84M Hold
400,000
0.08% 181
2023
Q1
$8.7M Buy
400,000
+107,551
+37% +$2.42M 0.09% 193
2022
Q4
$5.32M Hold
292,449
0.06% 244
2022
Q3
$6.65M Hold
292,449
0.08% 226
2022
Q2
$4.04M Hold
292,449
0.04% 336
2022
Q1
$6.65M Buy
292,449
+20,000
+7% +$527K 0.04% 326
2021
Q4
$10.2M Buy
272,449
+55,000
+25% +$2.36M 0.06% 280
2021
Q3
$9.2M Sell
217,449
-31,000
-12% -$1.49M 0.05% 291
2021
Q2
$11.1M Buy
248,449
+137,913
+125% +$4.86M 0.07% 265
2021
Q1
$3.98M Buy
+110,536
New +$4.37M 0.03% 446

Other funds holding BLFS

British Columbia Investment Management's BLFS Position: Q3 2023 in Review

British Columbia Investment Management sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 400,000 shares — an estimated $8.84M sold.

British Columbia Investment Management first reported a position in BLFS in Q1 2021 and held it in 10 quarters. The position peaked at $11.1M in Q2 2021. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • British Columbia Investment Management reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
  • British Columbia Investment Management sold 400,000 BioLife Solutions shares in Q3 2023, an estimated $8.84M.
  • British Columbia Investment Management first reported a position in BioLife Solutions in Q1 2021 and held it in 10 quarters.
  • British Columbia Investment Management's BioLife Solutions position peaked at $11.1M in Q2 2021.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on British Columbia Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.